Trial Profile
Efficiency of Combined Treatment of Barrett's Esophagus and Erosive Esophagitis by Proton Pump Inhibitors and Ursodeoxycholic Acid
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2011
Price :
$35
*
At a glance
- Drugs Ursodeoxycholic acid (Primary) ; Omeprazole
- Indications Barrett's oesophagus; Erosive oesophagitis
- Focus Therapeutic Use
- 08 Nov 2011 New trial record
- 26 Oct 2011 Results presented at the 19th United European Gastroenterology Week.